The Fund invests in companies addressing unmet medical needs or improving health care efficiencies by understanding the science and business of health care.

Janus Henderson Investors

Janus Henderson Investors International Limited

Other Equity

Equity

MSCI World/Health Care NR USD

Janus Henderson Glb Life Scn I2 HSGD

Janus Henderson Glb Life Scn I2 USD

2024

2023

2022

2021

2020

United States

United Kingdom

Switzerland

China

France

Denmark

Japan

Other countries

Unclassified

Healthcare

Eli Lilly and Co

UnitedHealth Group Inc

AstraZeneca PLC

Boston Scientific Corp

Abbott Laboratories

Johnson & Johnson

Sanofi SA

Amgen Inc

Novartis AG ADR

AbbVie Inc